| dc.contributor.author | Malhan, Berna Simten | |
| dc.contributor.author | Güler, Serdar | |
| dc.contributor.author | Yetkin, İlhan | |
| dc.contributor.author | Baeten, Steef | |
| dc.contributor.author | Verheggen, Bram | |
| dc.date.accessioned | 2021-11-01T14:58:11Z | |
| dc.date.available | 2021-11-01T14:58:11Z | |
| dc.date.issued | 2014 | |
| dc.identifier.citation | Malhan, S., Güler, S., Yetkin, I., Baeten, S., & Verheggen, B. (2014). Cost-effectiveness of exenatide twice daily (bid) added to basal insulin compared to a bolus insulin add-on in Turkey. Value in Health, 17(7), A349. | en_US |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.uri | https://doi.org/10.1016/j.jval.2014.08.722 | |
| dc.identifier.uri | https://hdl.handle.net/11491/6506 | |
| dc.description.abstract | Objectives
Type 2 diabetes (T2D) patients on basal insulin with uncontrolled HbA1c levels often receive an add-on with bolus insulin to lower HbA1c levels. The aim of this analysis is to estimate long-term cost-effectiveness of treating T2D patients with – a recently introduced – twice daily (BID) exenatide add-on to basal insulin strategy from a Turkish health care perspective. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.ispartof | Value In Health | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | [No Keywords] | en_US |
| dc.title | PDB100 - Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey | en_US |
| dc.type | conferenceObject | en_US |
| dc.department | Hitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| dc.identifier.volume | 17 | en_US |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | A349 | en_US |
| dc.identifier.endpage | A349 | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.department-temp | [Malhan, S.] Baskent Univ, TR-06490 Ankara, Turkey; [Guler, S.] Hitit Univ, Fac Med, Afatorum, Turkey; [Yetkin, I] Gazi Univ, Fac Med, Ankara, Turkey; [Baeten, S.; Verheggen, B.] Pharmerit Int, Rotterdam, Netherlands | en_US |
| dc.contributor.institutionauthor | Güler, Serdar | |
| dc.identifier.doi | 10.1016/j.jval.2014.08.722 | |
| dc.description.wospublicationid | WOS:000346917300146 | en_US |
| dc.description.pubmedpublicationid | PubMed: 27200672 | en_US |
